Drug production value of cardiovascular agents Japan 2022, by category
In 2022, the production value of antihypertensives in Japan amounted to around 306 billion Japanese yen, followed by hyperlipidemia agents with approximately 207 billion yen. The lowest drug production value had capillary stabilizers with only 20 million yen.